Advancing molecular-guided surgery through probe development and testing in a moderate cost evaluation pipeline-Reference-Cited by-同舟云学术

Advancing molecular-guided surgery through probe development and testing in a moderate cost evaluation pipeline

Published:2015-03-04 Issue: Volume: Page:
ISSN:0277-786X
Container-title:Molecular-Guided Surgery: Molecules, Devices, and Applications
language:
Short-container-title:

Author:

Pogue Brian W.,Paulsen Keith D.,Hull Sally M.,Samkoe Kimberley S.,Gunn Jason,Hoopes Jack,Roberts David W.,Strong Theresa V.,Draney Daniel,Feldwisch Joachim

Publisher

SPIE

Reference40 articles.

1. Optical Image-guided Surgery—Where Do We Stand?

2. Real-Time Intraoperative Ureteral Guidance Using Invisible Near-Infrared Fluorescence

3. Dual-Labeled Trastuzumab-Based Imaging Agent for the Detection of Human Epidermal Growth Factor Receptor 2 Overexpression in Breast Cancer

4. Quality analysis of in vivo near-infrared fluorescence and conventional gamma images acquired using a dual-labeled tumor-targeting probe

5. Single-Dose Intravenous Toxicity Study of IRDye 800CW in Sprague-Dawley Rats

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of a Suitable Untargeted Agent for the Clinical Translation of ABY-029 Paired-Agent Imaging in Fluorescence-Guided Surgery;Molecular Imaging and Biology;2021-10-12

2. Receptor-Targeted Fluorescence-Guided Surgery With Low Molecular Weight Agents;Frontiers in Oncology;2021-06-30

3. Development of a drug–device combination for fluorescence-guided surgery in neuroendocrine tumors;Journal of Biomedical Optics;2020-12-09

4. Image‐guided tumor surgery: The emerging role of nanotechnology;WIREs Nanomedicine and Nanobiotechnology;2020-03-11

5. A proof-of-concept methodology to validate the in situ visualization of residual disease using cancer-targeted molecular agents in fluorescence-guided surgery;Molecular-Guided Surgery: Molecules, Devices, and Applications VI;2020-02-19